Free Trial
NASDAQ:ICU

SeaStar Medical (ICU) Stock Price, News & Analysis

SeaStar Medical logo
$0.84 -0.21 (-20.15%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$0.85 +0.01 (+1.03%)
As of 11/13/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About SeaStar Medical Stock (NASDAQ:ICU)

Advanced

Key Stats

Today's Range
$0.81
▼
$1.08
50-Day Range
$0.84
▼
$4.69
52-Week Range
$0.81
▼
$5.38
Volume
598,114 shs
Average Volume
284,899 shs
Market Capitalization
$4.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Hold

Company Overview

SeaStar Medical Holding Corp. is a medical technology company developing extracorporeal therapies intended to address harmful inflammation in patients with critical illnesses. Its approach uses the Selective Cytopheretic Device (SCD), which processes blood outside the body and is designed to target activated immune cells associated with inflammation.

The company’s lead product, QUELIMMUNE, is an SCD-based therapy for certain pediatric patients with acute kidney injury and sepsis or a septic condition who require continuous kidney replacement therapy. The U.S. Food and Drug Administration granted the device a Humanitarian Device Exemption.

SeaStar Medical is also pursuing SCD applications for other serious conditions, including in adults. Its work centers on developing and evaluating device-based therapies for patients with life-threatening inflammatory conditions.

AI Generated. May Contain Errors.

SeaStar Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
75th Percentile Overall Score

ICU MarketRank™: 
3.738010773875 of 5 stars

SeaStar Medical scored higher than 75% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    SeaStar Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    SeaStar Medical has a consensus price target of $8.00, representing about 854.2% upside from its current price of $0.84.

  • Amount of Analyst Coverage

    SeaStar Medical has only been the subject of 1 research reports in the past 90 days.

  • Read more about SeaStar Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for SeaStar Medical are expected to grow in the coming year, from ($3.66) to ($2.09) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of SeaStar Medical is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of SeaStar Medical is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    SeaStar Medical has a P/B Ratio of 0.30. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.32% of the float of SeaStar Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    SeaStar Medical has a short interest ratio ("days to cover") of 1.33, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SeaStar Medical has recently decreased by 5.74%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    SeaStar Medical does not currently pay a dividend.

  • Dividend Growth

    SeaStar Medical does not have a long track record of dividend growth.

  • News Sentiment

    SeaStar Medical has a news sentiment score of 0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for SeaStar Medical this week, compared to 2 articles on an average week.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $2,452.00 in company stock, which represents 0.0550% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, SeaStar Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $2,452.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    0.70% of the stock of SeaStar Medical is held by insiders.

  • Percentage Held by Institutions

    1.69% of the stock of SeaStar Medical is held by institutions.

  • Read more about SeaStar Medical's insider trading history.
Receive ICU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SeaStar Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ICU Stock News Headlines

SeaStar Medical (NASDAQ:ICU) Stock Rating Lowered by Wall Street Zen
SeaStar Medical Q3 Revenue Rises 247% to $635,000
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel
SeaStar Medical (ICU) Q3 2026 Earnings Call Transcript
See More Headlines

ICU Stock Analysis - Frequently Asked Questions

SeaStar Medical's stock was trading at $2.40 on January 1st, 2026. Since then, ICU stock has decreased by 65.1% and is now trading at $0.8384.

SeaStar Medical Holding Corporation (NASDAQ:ICU) posted its quarterly earnings results on Wednesday, November, 11th. The company reported ($1.03) earnings per share for the quarter, missing analysts' consensus estimates of ($0.95) by $0.08. The company earned $635 thousand during the quarter, compared to analysts' expectations of $500 thousand. SeaStar Medical had a negative trailing twelve-month return on equity of 199.99% and a negative net margin of 678.24%.
Read the conference call transcript
.

SeaStar Medical's stock reverse split before market open on Monday, January 5th 2026.The 1-10 reverse split was announced on Tuesday, December 23rd 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, January 2nd 2026. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of ICU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SeaStar Medical investors own include Novo Integrated Sciences (NVOS), Faraday Future Intelligent Electric (FFAI), Advanced Micro Devices (AMD), Ardelyx (ARDX), Athersys (ATHX), Avalo Therapeutics (AVTX) and Bitfarms (BITF).

Company Calendar

Last Earnings
11/11/2026
Today
11/15/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:ICU
CIK
1831868
Fax
N/A
Employees
17
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$8.00
Potential Upside/Downside
+854.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.91)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.15 million
Net Margins
-678.24%
Pretax Margin
-678.11%
Return on Equity
-261.10%
Return on Assets
-149.15%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.03
Quick Ratio
1.02

Sales & Book Value

Annual Sales
$1.23 million
Price / Sales
3.63
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.75 per share
Price / Book
0.30

Miscellaneous

Outstanding Shares
5,320,000
Free Float
5,279,000
Market Cap
$4.46 million
Optionable
Not Optionable
Beta
-1.07
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NASDAQ:ICU) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners